Ingenol Mebutate Treatment in Actinic Keratosis – Clinical Effectiveness and Potential Side Effects

Postepy Dermatologii I Alergologii - Poland
doi 10.5114/ada.2019.87450
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses

Dermatology and Therapy
Dermatology
2012English

Disruption of Latent HIV in Vivo During the Clearance of Actinic Keratosis by Ingenol Mebutate

JCI insight
Medicine
2019English

Ablative Fractional Laser Improves Treatment of Actinic Keratoses With Ingenol Mebutate

European Journal of Inflammation
AllergyImmunology
2016English

Ingenol Mebutate: An Emerging Therapy in the Treatment of Actinic Keratoses

Current Dermatology Reports
Dermatology
2013English

Field Cancerization Therapy With Ingenol Mebutate Contributes to Restoring Skin-Metabolism to Normal-State in Patients With Actinic Keratosis: A Metabolomic Analysis

Scientific Reports
Multidisciplinary
2019English

Actinic Keratosis: A Clinical and Epidemiological Revision

Anais Brasileiros de Dermatologia
Dermatology
2012English

Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate

PLoS ONE
Multidisciplinary
2016English

Efficacy and Safety of Ingenol Mebutate in Patients With Actinic Keratosis on Face and Scalp: Subgroup Analysis of Two Vehicle-Controlled Trials According to Age (<65 and ≥65 Years)

SKIN The Journal of Cutaneous Medicine
2019English

Current and Emerging Treatment Strategies for the Treatment of Actinic Keratosis

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy